| scholarly article | Q13442814 |
| P50 | author | Gavin Birch | Q98188253 |
| P2093 | author name string | C Shipman | |
| N Williams | |||
| G Flynn | |||
| N Weiner | |||
| C Ramachandran | |||
| P2860 | cites work | Placebo-controlled trial of topical interferon in labial and genital herpes | Q69912315 |
| Protection of mice against fatal herpes simplex type 2 infection by liposomes containing muramyl tripeptide | Q70081994 | ||
| [Clinical study of the therapeutic effectiveness of an ointment consisting of swine leukocytic interferon] | Q71136592 | ||
| Efficacy of topical acyclovir cream in first and recurrent episodes of genital herpes | Q71194841 | ||
| The epidermal permeability barrier. Comparison between in vivo and in vitro lipid structures | Q71324189 | ||
| In vitro uptake and therapeutic application of liposome-encapsulated methotrexate in mouse hepatoma 129 | Q71844052 | ||
| Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form | Q71848916 | ||
| Comparison of lymphatic uptake, metabolism, excretion, and biodistribution of free and liposome-entrapped [14C]cytosine beta-D-arabinofuranoside following intraperitoneal administration to rats | Q72529875 | ||
| Liposomes—A selective drug delivery system for the topical route of administration: gel dosage form | Q72534904 | ||
| Binding and Capture of Human Interferon-Alpha by Reverse Evaporation Vesicles, Multilamellar Vesicles, and Small Unilamellar Vesicles | Q72674052 | ||
| Altered Pharmacologic Properties of Liposome-Associated Human Interferon-Alpha. II | Q72674099 | ||
| A microplaque reduction assay for human and mouse interferon | Q114738666 | ||
| Pyrrolo[2,3-d]pyrimidine nucleosides as inhibitors of human cytomegalovirus | Q28360591 | ||
| Therapy of genital herpes with topically applied interferon | Q35540898 | ||
| Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infection | Q35756016 | ||
| Genital herpes simplex. | Q35776249 | ||
| The clinical use of human leukocyte interferon in viral infections | Q40101681 | ||
| Prevention of Reactivated Herpes Simplex Infection by Human Leukocyte Interferon after Operation on the Trigeminal Root | Q40233489 | ||
| A microplaque reduction assay for human and mouse interferon | Q40341407 | ||
| Interferon therapy for condylomata acuminata | Q40804127 | ||
| Suppression of recurrent genital herpes simplex virus infection with recombinant alpha 2 interferon | Q40805580 | ||
| Potential applications of liposomes to therapy | Q40941332 | ||
| Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-acetylisoquinoline, and related compounds as inhibitors of herpes simplex virus in vitro and in a cutaneous herpes guinea pig model | Q42205956 | ||
| Treatment of recurrent genital herpes with topical alpha interferon gel combined with nonoxynol 9. | Q44905563 | ||
| Recombinant human interferon-alpha A treatment of an experimental cutaneous herpes simplex virus type 1 infection of guinea pigs | Q44936905 | ||
| Preparation of liposomes from stratum corneum lipids | Q45091354 | ||
| Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigs | Q46984784 | ||
| Fusion patterns of liposomes formed from stratum corneum lipids | Q68276279 | ||
| Systemic treatment of condylomata acuminata with recombinant interferon-alpha-2a: low-dose superior to the high-dose regimen | Q69719278 | ||
| Stratum corneum lipid liposomes: calcium-induced transformation into lamellar sheets | Q69727123 | ||
| Leukocyte interferon for treating first episodes of genital herpes in women | Q69812156 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1217-1221 | |
| P577 | publication date | 1989-08-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model | |
| P478 | volume | 33 |
| Q70767196 | Anti-inflammatory activity of hamamelis distillate applied topically to the skin. Influence of vehicle and dose |
| Q61444690 | Ascorbic acid encapsulated into negatively charged liposomes exhibits increased skin permeation, retention and enhances collagen synthesis by fibroblasts |
| Q51639059 | Comparison of absorption of aqueous lidocaine and liposome lidocaine following topical application on rabbit vessels. |
| Q83858395 | Development of novel fusogenic vesosomes for transcutaneous immunization |
| Q43597685 | Effect of liposomes and niosomes on skin permeation of enoxacin |
| Q53749395 | Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle. |
| Q41841747 | Formulation and optimization of Zidovudine niosomes |
| Q56035470 | Hydrogels and Their Combination with Liposomes, Niosomes, or Transfersomes for Dermal and Transdermal Drug Delivery |
| Q43543122 | In vitro skin permeation of estradiol from various proniosome formulations |
| Q72030030 | Interactions between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X-ray scattering studies |
| Q37909120 | Liposomal systems as drug delivery vehicles for dermal and transdermal applications |
| Q72143996 | Liposomal tretinoin for uncomplicated acne vulgaris |
| Q71943412 | Liposomally encapsulated diclofenac for sonophoresis induced systemic delivery |
| Q74159692 | Liposome associated interferon-alpha-2b functions as an anti-fibrogenic factor in dermal wounds in the guinea pig |
| Q41208681 | Liposomes |
| Q36636533 | Liposomes and biotherapeutics |
| Q36193206 | Liposomes and niosomes as topical drug delivery systems |
| Q79183418 | Liposomes and skin: past, present, future |
| Q40771126 | Liposomes for atopic dry skin: the rationale for a promising approach |
| Q40499118 | Liposomes: a novel topical delivery system for pharmaceutical and cosmetic applications |
| Q44837755 | Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. |
| Q34104557 | Non-invasive administration of drugs through the skin: challenges in delivery system design |
| Q77364359 | Palmitoyl derivatives of interferon alpha: potential for cutaneous delivery |
| Q33419739 | Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies |
| Q33809611 | Recurrent and Sustained Viral Infections in Primary Immunodeficiencies |
| Q46419771 | Tetanus toxoid-loaded transfersomes for topical immunization |
| Q33901042 | Therapeutic applications of colloidal drug carriers |
| Q35246287 | Topical delivery of liposomally encapsulated interferon evaluated by in vitro diffusion studies |
| Q77885946 | Transdermal iontophoretic delivery of enoxacin from various liposome-encapsulated formulations |
| Q46106589 | Transport of biologically active interferon-gamma across human skin in vitro |
| Q34041935 | Vaccine delivery: lipid-based delivery systems |
Search more.